Clinical Trial
doi: 10.1111/j.1600-0447.1989.tb06434.x.
Melperone in the treatment of schizophrenia
Affiliations
- PMID: 2479227
- DOI: 10.1111/j.1600-0447.1989.tb06434.x
Item in Clipboard
Clinical Trial
Melperone in the treatment of schizophrenia
Acta Psychiatr Scand Suppl.
1989.
Abstract
Eighty-one women with psychosis of schizophrenic or paranoid type participated in a double-blind comparison of melperone (300 mg daily) and thiothixene (30 mg daily). The purpose of the study was to analyse clinical and biochemical effects of the drugs. Both treatments were associated with significant reductions in psychotic morbidity. No significant difference in the clinical ratings was found between the drugs. However, there were more extrapyramidal side effects in the thiothixene as compared to the melperone group. Biochemically, the dopaminergic variables HVA in CSF and prolactin in plasma and CSF showed significantly greater elevations in the thiothixene group.
Similar articles
-
Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene.Arch Psychiatr Nervenkr (1970). 1977 Oct 11;224(2):107-18. doi: 10.1007/BF00346479. Arch Psychiatr Nervenkr (1970). 1977. PMID: 21644 Clinical Trial.
-
Relationships between clinical and biochemical effects of melperone and thiothixene in psychotic women.Arch Psychiatr Nervenkr (1970). 1979;227(3):181-92. doi: 10.1007/BF00367389. Arch Psychiatr Nervenkr (1970). 1979. PMID: 94992 No abstract available.
-
A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS.Arch Psychiatr Nervenkr (1970). 1978 Dec 14;226(3):157-72. doi: 10.1007/BF00341708. Arch Psychiatr Nervenkr (1970). 1978. PMID: 32861 Clinical Trial.
-
A clinical comparison of melperone and placebo in schizophrenic women on a milieu therapeutic ward.Acta Psychiatr Scand Suppl. 1989;352:40-7. doi: 10.1111/j.1600-0447.1989.tb06435.x. Acta Psychiatr Scand Suppl. 1989. PMID: 2573240 Clinical Trial.
-
A critical appraisal of CSF monoamine metabolite studies in schizophrenia.Ann N Y Acad Sci. 1988;537:309-23. doi: 10.1111/j.1749-6632.1988.tb42115.x. Ann N Y Acad Sci. 1988. PMID: 2462396 Review. No abstract available.
Cited by
-
Adverse effects of antipsychotic agents. Do newer agents offer advantages?Drugs. 1996 Jun;51(6):895-930. doi: 10.2165/00003495-199651060-00001. Drugs. 1996. PMID: 8736614 Review.
-
The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.Psychopharmacology (Berl). 1993;112(1 Suppl):S5-15. doi: 10.1007/BF02245003. Psychopharmacology (Berl). 1993. PMID: 7831440 Review.
-
Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.Psychopharmacology (Berl). 1993;112(1 Suppl):S40-54. doi: 10.1007/BF02245006. Psychopharmacology (Berl). 1993. PMID: 7530377
-
Auditing clinical outcomes after introducing off-licence prescribing of atypical antipsychotic melperone for patients with treatment refractory schizophrenia.ScientificWorldJournal. 2012;2012:512047. doi: 10.1100/2012/512047. Epub 2012 Apr 1. ScientificWorldJournal. 2012. PMID: 22566771 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical